MMP2 and cancer: DPPA was specifically cleaved from RDCM in response to matrix metalloproteinase-2 (MMP-2) that was overexpressed in the extracellular matrix of cancer cells to block PD-L1, DPPA together with IDO inhibition via 1MT alleviated the immunosuppression of CTLs by TME.